An increase in multidrug-resistant tuberculosis cases is being seen worldwide. Its management involves complex treatment, high costs, more toxic anti-tuberculosis drug use, longer treatment time and increased treatment failure and mortality. In India, access to key drugs is an added concern.
English 
हिन्दी